EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

A randomized controlled study of auricular point acupressure to manage chemotherapy-induced neuropathy: Study protocol

Nada Lukkahatai iD, Michael V Nguyen iD, Jingyu Zhang, Yu-Min Cho, Chitchanok Benjasirisan iD, Heijingzi Monica Jia, Claudia M Campbell, Jennifer Kawi, Hulin Wu, Hongyu Wang, Rupsikha Bora, Johannes Thrul und 2 weitere

PLOS ONE · 26.09.2024 · 19 (9) · e0311135

DOI: 10.1371/journal.pone.0311135 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS ONE, online erschienen am 26.09.2024. Verfasst von Nada Lukkahatai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University School of Nursing, Baltimore, MD, United States of America. Hauptthemen laut MEDLINE: Acupressure, Antineoplastic Agents, Quality of Life. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Chemotherapy-induced neuropathy (CIN) significantly impacts cancer patients, leading to functional disability, diminished quality of life, and increased healthcare costs amid the ongoing opioid crisis. Auricular point acupressure (APA), a non-invasive and non-pharmacological alternative, has shown potential for alleviating the pain, numbness, and tingling associated with CIN. This study aims to assess the efficacy of APA for CIN symptoms and physical function and to examine the mechanisms underlying APA’s effects on CIN.

Methods

This is a three-arm randomized controlled clinical trial protocol. Patients aged 18 and older who are experiencing CIN are randomly assigned to one of the three groups: an APA group (in-person APA; mAPA), a sham control group (virtual APA; vAPA), and a wait-list usual care control group (UC). During the four-week program, participants in the mAPA receive an in-person APA treatment and training; the sham control participants (vAPA) receive a self-guided smartphone APA application with APA demonstration videos; and the UC participants will continue with the usual care and be re-randomized into one of the APA groups. The primary outcomes are changes in CIN symptoms and physical function. Secondary outcomes include evaluating pain sensory thresholds, motor and cognitive functioning, inflammatory signaling, brain connectivity, opioid use, and quality of life. The outcomes are measured at baseline, program completion (4 weeks), and at monthly follow-up for 3 months post-intervention.

Discussion

This study will provide evidence supporting the potential viability of APA as an intervention for CIN.

Trial registration

ClinicalTrials.gov, ID NCT04920097 registered on 3 June 2021.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcupressureAntineoplastic AgentsQuality of LifeAdultFemaleHumansMaleMiddle AgedNeoplasmsPeripheral Nervous System DiseasesRandomized Controlled Trials as Topic

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Johns Hopkins University School of Nursing, Baltimore, MD, United States of America.
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, United States of America.
  • The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, United States of America.
  • The University of Texas Health Science Center at Houston, Cizik School of Nursing, Houston, TX, United States of America.
  • Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.
  • Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.

ORCID-Profile: Nada Lukkahatai, Michael V Nguyen, Chitchanok Benjasirisan

Förderung

  • NCI NIH HHS
  • National Cancer Institute of the National Institutes of Health

Zitieren

APA

Lukkahatai, N., Nguyen, M. V., Zhang, J., Cho, Y. M., Benjasirisan, C., Jia, H. M., Campbell, C. M., Kawi, J., Wu, H., Wang, H., Bora, R., Thrul, J., Johnson, C. M., & Smith, T. J. (2024). A randomized controlled study of auricular point acupressure to manage chemotherapy-induced neuropathy: Study protocol. PLOS ONE, 19(9), e0311135. https://doi.org/10.1371/journal.pone.0311135

Vancouver

Lukkahatai N, Nguyen MV, Zhang J, Cho YM, Benjasirisan C, Jia HM, et al. A randomized controlled study of auricular point acupressure to manage chemotherapy-induced neuropathy: Study protocol. PLOS ONE. 2024;19(9):e0311135. doi:10.1371/journal.pone.0311135

BibTeX
@article{Lukkahatai2024,
  author = {Lukkahatai, Nada and Nguyen, Michael V and Zhang, Jingyu and Cho, Yu-Min and Benjasirisan, Chitchanok and Jia, Heijingzi Monica and Campbell, Claudia M and Kawi, Jennifer and Wu, Hulin and Wang, Hongyu and Bora, Rupsikha and Thrul, Johannes and Johnson, Constance M and Smith, Thomas J},
  title = {A randomized controlled study of auricular point acupressure to manage chemotherapy-induced neuropathy: Study protocol},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {9},
  pages = {e0311135},
  doi = {10.1371/journal.pone.0311135}
}
Kostenlos starten →